Literature DB >> 24056940

Sterol 3β-glucosyltransferase biocatalysts with a range of selectivities, including selectivity for testosterone.

Vatsala Malik1, Meng Zhang, Lynn G Dover, Julian S Northen, Anthony Flinn, Justin J Perry, Gary W Black.   

Abstract

The main objectives of this work were to characterise a range of purified recombinant sterol 3β-glucosyltransferases and show that rational sampling of the diversity that exists within sterol 3β-glucosyltransferase sequence space can result in a range of enzyme selectivities. In our study the catalytically active domain of the Saccharomyces cerevisiae 3β-glucosyltransferase was used to mine putative sterol 3β-glucosyltransferases from the databases. Selected diverse sequences were expressed in and purified from Escherichia coli and shown to have different selectivities for the 3β-hydroxysteroids ergosterol and cholesterol. Surprisingly, three enzymes were also selective for testosterone, a 17β-hydroxysteroid. This study therefore reports for the first time sterol 3β-glucosyltransferases with selectivity for both 3β- and 17β-hydroxysteroids and is also the first report of recombinant 3β-glucosyltransferases with selectivity for steroids with a hydroxyl group at positions other than C-3. These enzymes could therefore find utility in the pharmaceutical industry for the green synthesis of a range of glycosylated compounds of medicinal interest.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24056940     DOI: 10.1039/c3mb70303g

Source DB:  PubMed          Journal:  Mol Biosyst        ISSN: 1742-2051


  2 in total

1.  Kinetic studies on recombinant UDP-glucose: sterol 3-O-β-glycosyltransferase from Micromonospora rhodorangea and its bioconversion potential.

Authors:  Nguyen Huu Hoang; Nguyen Lan Huong; Byul Kim; Je Won Park
Journal:  AMB Express       Date:  2016-08-02       Impact factor: 3.298

2.  The enzymatic biosynthesis of acylated steroidal glycosides and their cytotoxic activity.

Authors:  Ming Liu; Jian-Qiang Kong
Journal:  Acta Pharm Sin B       Date:  2018-05-01       Impact factor: 11.413

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.